Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy license

Orchid Pharma collaborates with Cipla to unveil antibiotic Cefepime-Enmetazobactam in India

Ruchika Sharma29 Jun 2024 12:00 PM IST

New Delhi: Orchid Pharma Limited, based in Chennai, India, the only Indian pharmaceutical company to have ever invented a New Chemical Entity...

Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration

Roche Vabysmo gets CHMP recommendation for third indication retinal vein occlusion

Ruchika Sharma29 Jun 2024 10:00 AM IST

Basel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...

Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug Macitentan

Alembic Pharma secures USFDA okay for Doxycycline Capsules for inflammatory lesions of rosacea

Ruchika Sharma28 Jun 2024 5:41 PM IST

Alembic Pharmaceuticals Limited today announced that the Company has received final approval from the US Food & Drug Administration (USFDA) for...

USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plant

Jubilant Ingrevia receives USFDA EIR for Baruch facility

Ruchika Sharma28 Jun 2024 12:30 PM IST

Noida: Jubilant Ingrevia Limited has announced successful outcome of the USFDA inspection with the receipt of Establishment Inspection report...

Lupin receives USFDA observations for two Pithampur manufacturing Units

Lupin bags USFDA tentative nod for Olopatadine Hydrochloride Ophthalmic Solution(OTC)

Ruchika Sharma28 Jun 2024 11:30 AM IST

The solution is indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander.

AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib

USFDA issues complete response letter for Patritumab Deruxtecan in EGFR-Mutated NSCLC: Merck, Daiichi Sankyo

Ruchika Sharma28 Jun 2024 10:00 AM IST

Rahway: The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA)...

Merck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billion

Merck discontinues Phase 3 trial of Xevinapant in locally advanced head and neck cancer

Ruchika Sharma27 Jun 2024 5:04 PM IST

Germany: Merck, a science and technology company, has announced the discontinuation of the Phase III randomized TrilynX study evaluating...

Aurobindo Pharma in lead to acquire Zentiva for US 5.5 billion: ET Report

Aurobindo Pharma arm Telangana injectable unit gets USFDA VAI classification

Ruchika Sharma27 Jun 2024 3:03 PM IST

Telangana: Aurobindo Pharma has informed in a BSE filing that the injectable facility of Eugia SEZ Pvt. Ltd., a 100 per cent step-down subsidiary...

Physical assault attempt on TRIHMS director after ransacking his private residence

Maha: Drug inspector, 1 other arrested for taking Rs 1 lakh bribe

Ruchika Sharma27 Jun 2024 1:59 PM IST

As per the complaint, drug inspector allegedly demanded the bribe from the man, who runs a medical store at Nalasopara in the district.

Sun Pharma, Zydus and Glenmark recall various products in US over manufacturing issues

Glenmark Pharma recalls 114 batches of hypokalemia drug Potassium Chloride Extended Release in US

Ruchika Sharma27 Jun 2024 12:20 PM IST

Mahwah: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ is voluntarily recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750...

Healthcare Industry gets 'B+' on Cybersecurity for 2024

Ruchika Sharma27 Jun 2024 10:00 AM IST

New York: A new research by SecurityScorecard highlights both the robust security and significant vulnerabilities facing the U.S. healthcare...

Bharat Biotech to lead further development of GSK Shigella vaccine

Bharat Biotech adds ICMR as co-owner of COVID vaccine patent

Ruchika Sharma26 Jun 2024 4:13 PM IST

Hyderabad: The Indian Council of Medical Research (ICMR) has been added as co-owner of the Covid-19 vaccine patent by Bharat...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok